Acurox NDA Returns To FDA Without Niacin, But With More Dosing Flexibility
This article was originally published in The Pink Sheet Daily
Executive Summary
King and Acura are refiling the abuse-resistant oxycodone, this time without the addition of vitamin B3 that FDA and an advisory panel said would do no good at stopping abuse.